President
CurrentAs a President, I supervise and manage a $50M P&L functions, seamlessly integrating legacy operations with M&A activities and launching De Novo facilities and service lines. Leveraging my key expertise, I drive $221M in revenue for NYC’s private therapeutic schools and spearhead the establishment of De Novo centers in NV, IA, ME, and MN. Additionally, I oversee a $15M De Novo budget for 2023, ensuring a robust ramp-up and leading M&A activities surrounding ABA programs in IL and TX.Key Contributions:☛ Built an ABA network across four states, overcoming complex geographical and regulatory challenges to achieve a $12M run rate in the first year and $15M in the second year.☛ Expanded the ABA network to five states and ten centers, fueling a $13M annualized run rate through strategic growth and optimization.☛ Orchestrated the successful merger of the Texas ABA Program with a respected Texas brand, resulting in a 17% revenue boost and a 20% increase in EBITDA within 60 days.☛ Revitalized Reno, Nevada operations to cash flow positive within 90 days by forging strategic partnerships with client behavioral hospitals, cultivating relationships with UNR, and implementing targeted cost reductions.☛ Accelerated the Maine ABA program from $0 in March 2020 to approximately $93,000 by November 2020, achieving ~30% margins by introducing a new service line that capitalized on emerging market needs.☛ Increased revenue for NYC private therapeutic schools from $204M to $221M by developing and launching new programs for the 18+ population, addressing a critical service gap.☛ Achieved a 12% Y-o-Y census growth for PRTF by expertly navigating COVID-related challenges and adapting service delivery models.☛ Exceeded forecasted pro forma by ~10% hours’ network-wide through strategic planning and precise execution